Overall, 56 of the 68 samples or 82% expressed either MYB or MYBL1. Interestingly, none of the samples expressed both MYB and MYBL1, consistent with the hypothesis that these are the interchangeable driver oncogenes for most ACC tumors – there is no need or selection pressure for a tumor to express both. Here, MYB is linked to adrenal cortex carcinoma.